Status:
COMPLETED
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Anemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study will assess the efficacy and safety of intravenous (iv) Mircera given as maintenance treatment for renal anemia in chronic kidney disease patients on dialysis who were previously receiving ...
Eligibility Criteria
Inclusion
- adult patients \>=18 years of age;
- chronic renal anemia;
- on dialysis therapy for at least 12 weeks before screening;
- receiving darbepoetin alfa iv for at least 8 weeks before screening.
Exclusion
- women who are pregnant, breastfeeding or using unreliable birth control methods;
- administration of another investigational drug within 4 weeks before screening, or during the study period.
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2005
Estimated Enrollment :
313 Patients enrolled
Trial Details
Trial ID
NCT00077766
Start Date
March 1 2004
End Date
August 1 2005
Last Update
October 26 2016
Active Locations (48)
Enter a location and click search to find clinical trials sorted by distance.
1
Blacktown, Australia, NSW 2148
2
Brisbane, Australia, 4102
3
Clayton, Australia, 3168
4
Gosford, Australia, 2250